GlassScriptPhysician profile
Nisha Wali
NPI 1780351841
$1,297.17
in general payments reported to CMS, 2019-2025
6 companies · $744 in 2025
The $744 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $350 · 2024: $203 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.18 |
| Education | $171.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $494.49 | 2023-2025 | Jakafi, Monjuvi, Niktimvo |
| Sanofi-Aventis U.S. LLC | $255.66 | 2025 | |
| Gilead Sciences, INC. | $213.40 | 2023 | Trodelvy |
| Teleflex LLC | $167.59 | 2025 | Arrow |
| E.R. Squibb & Sons, L.L.C. | $148.10 | 2025 | Reblozyl |
| Daiichi Sankyo INC. | $17.93 | 2025 | Vanflyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Wali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.